BSc, MSc, MBPsS, MPhil
DPhil Candidate & Junior Dean
I am interested in behavioural interventions for the management of disorders and disease. I have focused on childhood obesity, vitamin deficiency, and dyslipidaemia as exemplar health outcomes. My expertise spans qualitative methodology, feasibility testing, and randomised controlled trials.
My doctoral research aims to develop an intervention to manage obesity in people with serious mental illness. In 2019, I was awarded the Division of Medical Sciences doctoral scholarship. I also serve as a Junior Dean at Brasenose College, Oxford.
I trained in Psychology and Language at UCL. My research won first prize at the Faculty of Brain Sciences annual conference. In 2015, I received two scholarships to train in Clinical Neurodevelopmental Sciences at the Institute of Psychiatry, King's College London. I later received the Sackler Institute Award for highest overall mark. In 2016, I returned to UCL at the Great Ormond Street Institute of Child Health. In 2018, I joined Oxford.
Awards and Scholarships
Senior Hulme scholarship for academic excellence (2021), University of Oxford
Doctorate scholarship, Medical Sciences Division graduate school (2019), University of Oxford
Sackler Institute award for academic excellence (2016), King's College London
Postgraduate scholarship (2015), Leverhulme Trade Charities Trust and King's College London
Lee C. et al, (2021), BMJ Open, 11
Albury C. et al, (2021), International journal for quality in health care : journal of the International Society for Quality in Health Care, 33
Lee CL. et al, (2021), Nutrients, 13
Tanna N. et al, (2021), Public Health Nutrition, 1 - 60
Primary Care Shopping Intervention for Cardiovascular Disease Prevention, NIHR ARC and the NIHR Oxford BRC, Co-Investigator, Oct 2018-Oct-2019.
A randomised controlled trial to compare two different doses of maternal B12 supplementation in improving infant B12 deficiency and neurodevelopment, MRC, Co-Investigator, Oct 2018-Sept 2021.
Patient and public involvement prioritisation pilot, ARC West London and Internis Pharmaceuticals, Co-Investigator, 2018.